44 algorithm-development-"Multiple"-"Prof"-"Prof"-"Simons-Foundation" Postdoctoral positions at Yale University in United States
Sort by
Refine Your Search
-
School of Medicine (www.patel-lab.org). Our laboratory has a highly translational focus, with the overall goal of developing non-invasive diagnostic tools for early detection and surveillance of cancer
-
. Experience working with rodent models is preferred but not required. The successful candidate should have excellent oral and written communication skill, be highly motivated for career development in
-
to develop their emotional intelligence. Our work focuses on (1) the development and impact of social and emotional skills among diverse populations, including education settings and organizations, and (2
-
independently and collaboratively, desiring to develop and/or adapt novel approaches in biochemistry, molecules and genetics, and PhD in Neuroscience and related disciplines. However, auditory and hearing
-
project We are seeking highly motivated postdoctoral researchers in biomedical informatics and data science to work on projects focused on the development of biomedical blockchain, clinical predictive
-
data-driven knowledge to the development of next-generation regenerative therapeutics. Our group is a multidisciplinary lab at Yale within the Department of Anesthesiology, the Vascular Biology
-
cellular biology, and work in a vibrant and collaborative environment. The Alon Lab encourages career development through opportunities to lead collaborations, mentor junior trainees, and present research
-
environment. Ability to mentor and train junior team members in both clinical and molecular techniques. Commitment to maintaining high standards of laboratory safety and regulatory compliance. Experience with
-
Postdoctoral Associate in Computational Neuroscience at Yale The Post-Doctoral Associate will develop predictive, gene-regulatory networks linked to Parkinson’s and other neurological diseases in
-
are one of the most exciting areas of cancer biology. Many novel strategies for targeting RAS are in clinical trial, and many more are in development and are advancing to clinical trials. The Stites lab’s